Legend Biotech Corp Financial Liabilities At Fair Value Through Profit Or Loss
Legend Biotech Corp (LEGN) had Financial Liabilities At Fair Value Through Profit Or Loss of $0 as of 2024-12-31, per its 20-F filed 2025-03-11.
Financial Statements › Notes
ifrs-full:FinancialLiabilitiesAtFairValueThroughProfitOrLoss · last filed 2025-03-11
- 2024-12-31: Financial Liabilities At Fair Value Through Profit Or Loss $0.00.
- 2023-12-31: Financial Liabilities At Fair Value Through Profit Or Loss $0.00.
- 2022-12-31: Financial Liabilities At Fair Value Through Profit Or Loss $67.00M.
- 2021-12-31: Financial Liabilities At Fair Value Through Profit Or Loss $87.90M.
| Period end | Financial Liabilities At Fair Value Through Profit Or Loss |
|---|---|
| 2024-12-31 | $0.00 20-F · filed 2025-03-11 |
| 2023-12-31 | $0.00 20-F · filed 2025-03-11 |
| 2022-12-31 | $67.00M 20-F · filed 2024-03-19 |
| 2021-12-31 | $87.90M 20-F · filed 2023-03-30 |
| 2021-06-30 | $83.30M 6-K · filed 2021-08-23 |